Withdrawal Notice

This paper was originally published in Aging Advance Online Publications on March 14, 2024.

In compliance with Aging's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Aging internal or any external indexes or archives.

WITHDRAWN: Metformin mitigates cisplatin-induced ovarian damage through inhibiting the pyroptosis of granulosa cells via ROS/TXNIP/NLRP3 signaling pathway

Bo Wang1,2,3, , Jian Li4, , Qianyu Zhang1,2,3, , Yuting Li1,2,3, , Wu Ren1,2,3, , Du He5, ,

  • 1 Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
  • 2 National Clinical Research Center for Obstetrical and Gynecological Diseases, Wuhan 430030, China
  • 3 Key Laboratory of Cancer Invasion and Metastasis, Ministry of Education, Wuhan 430030, China
  • 4 Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, Wuhan 430030, China
  • 5 Department of Medical Oncology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi 445000, China

Received: October 9, 2023       Accepted: January 29, 2024       Published: March 14, 2024      


Copyright: © 2024 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.